samedan logo
home > ict > summer 2020 > the new york hot zone
International Clinical Trials

The New York Hot Zone

EPC: What is it like being front and centre in clinical trial management during COVID-19?

Dr Christina Brennan: I'm sure it’s been all over the news worldwide, but New York really was the epicentre of this pandemic in the US, and that was significant for us in the management of the trials. We decided very early on, in March, to quickly form a COVID clinical trials unit. One of the first things that we decided was to put all of our non-COVID trials on hold with the exception of oncology trials – we felt that was important, as patients were receiving active treatment. Any other trials were looked at on a caseby- case basis. After that decision, and the COVID clinical trials unit was formed, we then decided that the trials that we were going to open would only be for hospitalised patients. At the time, many employees went remote, and we did have hesitation around employees who wanted to come to the hospitals versus those working remotely, so we had to be selective in the trials that we decided to participate in.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:

There are no comments in regards to this article.

About the Author

Dr Christina Brennan has devoted her career to clinical research and currently serves at The Feinstein Institutes for Medical Research as Northwell Health’s Vice President of Clinical Research. Committed to the advancement of science and medicine. Dr Brennan has more than 20 years of extensive clinical research experience, including over 15 years in clinical research management roles. She is on the board of trustees for the Association of Clinical Research Professionals, and most recently, she has been appointed to the Society for Clinical Research Sites’ Leadership Council.
Print this page
Send to a friend
Privacy statement
News and Press Releases

Luina Bio Announces New Bio-Manufacturing GMP And Development Facility Expansion

1st September 2020 Highlights • Small scale GMP manufacturing suites open in Q3 2020 • 500L tech transfer and process development site aim for open Q4 2020 • This precedes the next phase with Luina planning to commission a 10,000m2 late phase clinical and commercial production facility targeting late 2021 • New facilities capture more of the global value chain supporting technically advanced microbiome projects • New expanded capacity for bacterial and yeast recombinant projects including vaccine manufacturing including COVID-19 candidates
More info >>

White Papers



Groth et al., 2007 and Jasencakova et al., 2010 Protein:protein-interactions (PPI) govern almost all important processes in living organisms. Thus, their rapid and accurate determination and investigation is a major challenge in life sciences. The extremely efficient and fast One-STrEP (Twin-Strep) system is suitable for the isolation of functional protein complexes and subsequent mass spectrometry analysis leads to the identification of protein complex components (Junttila et al., 2005) as it is shown in the following studies.
More info >>

Industry Events

CPhI Festival of Pharma

5-16 October 2020, Virtual

A virtual gathering for the pharmaceutical industry, the CPhI Festival of Pharma has been created to fill the gap left by in-person events at a time when travel and gatherings are off the cards.
More info >>



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement